Health SystemsHelix Debuts Novel Precision Effectiveness Model That Predicts 12-Month Weight Loss Response of Semaglutide in Diverse PopulationsNovember 13, 2024
Health SystemsHelix to Showcase the Impact of Clinico-Genomic Research on Clinical Care and Drug Discovery at ASHG Annual MeetingOctober 30, 2024
Population GenomicsOptimizing Mammogram Screenings: A Genetic Approach to a Personalized Screening ScheduleDecember 29, 2023
Helix ResearchDon’t Forget The Highest Risk: Why Polygenic Risk Scores Alone Aren’t EnoughJune 21, 2023
Helix PartnersCombining rare and common genetic variants improves population risk stratification for breast cancerMay 19, 2023
Public HealthExome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics InitiativeNovember 3, 2022
Helix ResearchPower Window Method Improves the Ability to Evaluate Clinical Impact by 2.4xAugust 3, 2022
Population GenomicsThe Case for Incorporating TTN Variant Testing into Routine Heart Disease ScreeningJune 15, 2022
Helix ResearchOne of the largest gene-based collapsing analyses reveals potential candidate genes for population screeningAugust 3, 2021
